Lund Melanoma Study Group
191 – 200 of 225
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 1999
-
Mark
Cancer risks in BRCA2 mutation carriers
(
- Contribution to journal › Article
-
Mark
A review of the epidemiology of soft tissue sarcoma
(
- Contribution to journal › Article
-
Mark
Clinical and histopathological characteristics in relation to aetiological risk factors in cutaneous melanoma : a population-based study
(
- Contribution to journal › Article
-
Mark
Correlation between p53, c-erbB-2, and topoisomerase II alpha expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas : prognostic implications
(
- Contribution to journal › Article
- 1998
-
Mark
Blood transfusion at delivery and risk of subsequent malignant lymphoma in the mother
(
- Contribution to journal › Article
-
Mark
Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group
(
- Contribution to journal › Article
-
Mark
Clinical course of early onset prostate cancer with special reference to family history as a prognostic factor
(
- Contribution to journal › Article
-
Mark
Relapse rate, renal survival, and cancer morbidity in patients with Wegener's granulomatosis or microscopic polyangiitis with renal involvement
(
- Contribution to journal › Article
-
Mark
Forskningsframsteg om hereditär prostatacancer. Riskfamiljer bör kartläggas och erbjudas screening
(
- Contribution to journal › Article
-
Mark
Survival of BRCA1 breast and ovarian cancer patients : a population-based study from southern Sweden
(
- Contribution to journal › Article